Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000233683 is a pseudogene that is similar to a part of the ribosomal protein L6 (RPL6) gene. By definition, a pseudogene is a segment of DNA that bears high homology to a functional gene but is incapable of producing a functional protein product[2][4][7]. Such pseudogenes are considered “non-functional” elements; they may be transcribed at low levels, but do not have established protein-coding or therapeutic relevance[4][7]. This pseudogene does not encode a functional protein and is not considered a valid drug target or involved in classical biological or disease processes. There are no known interacting drugs, functional mechanisms, or known biomarker or safety concerns associated with this pseudogene. Key points: - The molecule is not a true protein or receptor: it is a genomic pseudogene[2][4][7]. - Not a therapeutic target: does not encode an enzyme, receptor, transporter, transcription factor, or similar functional molecule[2][4][7]. - Not a receptor and does not have signaling or structural roles in human biology[2][4][7]. - Sometimes pseudogenes are aberrantly annotated as possible targets in some resources, but in standard gene nomenclature curation, they are annotated as non-functional elements[2][4][7]. If you require data for the functional ribosomal protein L6 instead, it is a component of the 60S ribosomal subunit with roles in protein biosynthesis and DDR (DNA damage response), but ENSG00000233683 itself is only a non-functional pseudogene[5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ribosomal protein L6 (RPL6).